References
Konstantinides SV, Torbicki A, Agnelli G et al (2014) Task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35:3033–3069
Laporte S, Mismetti P, Decousus H et al (2008) Clinical predictors for fatal pulmonary embolism in 15.520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 117:1711–1716
Bajaj A, Rathor P, Sehgal V et al (2015) Prognostic value of biomarkers in acute non-massive pulmonary embolism: a systematicreview and meta-analysis. Lung 193:639–651
Gul EE, Can I, Kayrak M et al (2014) Thrombolysis in patients with pulmonary embolism and elevated heart type fatty acid-binding protein levels. J Thromb Thrombolysis 37:483–489
Baral R, Luo X, Watanabe H, Yamasawa I, Ibukiyama C (1994) Role of MB isoforms (isomers) in the early diagnosis of acute myocardial infarction. Intern Med 33:210–215
Bozbay M, Uyarel H, Avsar S et al (2015) Creatinine kinase isoenzyme-MB: a simple prognostic biomarker in patients with pulmonary embolism treated with thrombolytic therapy. J Crit Care. doi:10.1016/j.jcrc.2015.07.014
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There are no conflicts of interest issues. We have no grant support.
Rights and permissions
About this article
Cite this article
Bozbay, M., Uyarel, H. Creatinine Kinase Isoenzyme MB: A Simple Prognostic Marker for Pulmonary Embolism. Lung 194, 175–176 (2016). https://doi.org/10.1007/s00408-015-9819-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-015-9819-2